Obstructive Lung Diseases Completed Phase 2 Trials for Tretinoin (DB00755)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000621Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)Treatment